MedPath

Pilot Internet-based Self-Help Program for Managing Corona (COVID-19) Stress

Not Applicable
Conditions
Stress
Stress, Psychological
Registration Number
NCT04394403
Lead Sponsor
Hebrew University of Jerusalem
Brief Summary

The current study examines an adapted guided self-help stress reduction program, focusing on reducing stress in the time of COVID-19. Two studies are planned: 1) an international study in English in which individuals proficient in English throughout the world will participate and 2) a follow-up study in Hebrew.

Detailed Description

The current study examines an adapted guided self-help stress reduction program, focusing on reducing stress in the time of COVID-19. Two studies are proposed: 1) an international study in English in which individuals proficient in English throughout the world will participate and 2) a study in Hebrew. The first study will publicize via social media and participants will be randomized to either immediate participation or a 6 week waitlist period. Assessments will be conducted pre, (again after waitlist for the control group), posttx (after completion/cessation of the program), 6 month and 1 year followup. Two forms of assessment will be conducted: pre-post-follow-up (with the CRISIS measure) and weekly during the program (via the DASS-21). For the full program see: https://www.iterapi.se/sites/coronastress/

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
120
Inclusion Criteria
  • Read/Write English,
  • feels stress due to Corona/COVID-19
Exclusion Criteria
  • current psychological or psychiatric treatment,
  • current psychiatric illness,
  • suicidality,
  • psychosis,
  • bipolar,
  • severe dissociative symptoms,
  • in a currently severe traumatic situation,
  • having a serious medical illness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The CoRonavIruS Health Impact Survey (CRISIS)change from Pre to 1 year Follow-up

change in a self-report measure of stress during the COVID-19 pandemic that ranges from 0-128. Higher means more symptomatic.

Secondary Outcome Measures
NameTimeMethod
Depression, Anxiety, and Stress Scale- 21 item version: DASS-21change from pre to 1 year follow-up

a self-report measure of depression, anxiety and stress, with each subscale ranging from 0-28. Higher means more symptomatic.

Trial Locations

Locations (1)

Hebrew University of Jerusalem

🇮🇱

Jerusalem, Israel

Hebrew University of Jerusalem
🇮🇱Jerusalem, Israel
Jonathan Huppert, PhD
Contact
+97225883376
coronastress@mail.huji.ac.il
Jonathan D Huppert, PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.